Supreme Court backs Oklahoma lethal injection drug; AbbVie expands in Ireland; Roche wins new EU nod for Perjeta;

@FiercePharma: Novartis shells out $200M-plus for Spinifex and its mid-stage pain drug. FiercePharmaMarketing item | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: France's TxCell closes its plant at ANSM urging to avoid contamination. Story | Follow @EricPFierce

@CarlyHFierce: Can Allergan make double-chin drug pay off? Maybe, but slowly, analysts say. More | Follow @CarlyHFierce

> The U.S. Supreme Court said a drug used by Oklahoma in lethal injections, midazolam, does not violate a constitutional ban on cruel and unusual punishment. Report

> AbbVie ($ABBV) said it would expand its drug delivery facility in Sligo, Ireland, with 50 new jobs and a €40 million investment over four years. Release

> Roche's ($RHHBY) Perjeta won a European recommendation for use before surgery in women with HER2-positive breast cancer. Release

> Cost-effectiveness watchdogs in England bowed to pressure to reopen comments about new draft guidelines for treating diabetes, which have drawn considerable fire since the agency first unveiled them. Report

> Merck KGaA says it plans to add another 250 employees at Sigma-Aldrich ($SIAL) production sites in Israel as soon as its buyout of the devices company is approved by regulators. Report

> India-based Lupin says it's looking for alliances and "strategic brand acquisitions" to build up its business in the U.S. Report

> Samsung Bioepis said it's considering going public in the U.S. to raise money to develop more biosimilar drugs. Report

Medical Device News

@FierceMedDev: ICYMI: FDA gives nod to newest pelvic mesh product, despite ongoing safety issues. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Bard VP touts new study of its Lutonix drug-coated balloon to fight PAD. Article | Follow @VarunSaxena2

@EmilyWFierce: EU stands by crackdown on drug spending in Ireland. FiercePharma story | Follow @EmilyWFierce

> Former OtisMed CEO sentenced to two years in prison for shipping device after FDA rejected it. Article

> Olympus faces new suit from UCLA superbug patient over duodenoscope deviceFacing off rivals, Merck looks to expand CINV label on positive PhIII Emend study. Story

> Wearable, badge-based hand-washing monitoring system improves hospital staff compliance. Report

Biotech News

@FierceBiotech: Facing off rivals, Merck looks to expand CINV label on positive PhIII Emend study. Story | Follow @FierceBiotech

@JohnCFierce: These guys at Spinifex are smart--Giant Novartis downs a pain med in $200M-plus buyout of tiny Spinifex. More | Follow @JohnCFierce

@DamianFierce: From BIO last week, here's $QURE CEO Aldag talking about $CLDN, $AAVL and the future of gene therapy. Listen | Follow @DamianFierce

> AMAG snags Cord Blood Registry for $700M. Item

> Egalet's pain pill is tougher to abuse than Purdue's morphine tablet, study shows. Report

Animal Health News

> Egg prices soar, menu items dropped in wake of historic avian flu. More

> Investors erase Zoetis gains as questions emerge about Valeant's pursuit. Report

> Sorrento nabs key FDA designation for nonopiate drug to treat bone pain in dogs. Item

> Scottish scientists design piglets to resist African swine fever. Story

> Henry Schein expands global reach, taking majority stake in Denmark's Kruuse. Article

Biotech IT News

> Eisai strikes extensive multiyear IT outsourcing deal with Accenture. News

> Google steps up wearables plan with clinical trial-focused wristband. Story

> Analyst: R&D time pressures mean clinical trial tech and automation are finally taking off. More

> Google to pair its cloud-computing power with Broad's analytic tools. Article

> SEC starts pursuit of biotech-focused hacking ring. Report

Pharma Marketing News

> Novartis shells out $200M-plus for Spinifex and its mid-stage pain drug. News

> Should Bristol-Myers cut payer deals to boost melanoma combo over one-drug treatments? More

> Will pharma jump into an EHR app store near you? Don't count on it anytime soon. Story

> Nuedexta maker Avanir taps actor Danny Glover to shed light on little-known neurological condition. Article

And Finally... As fears over dengue fever grow in Japan, sales of a mosquito-repelling fabric from Teijin Frontier have skyrocketed. Report

Suggested Articles

China's role as a major producer of global API has come under scrutiny, but so far global tensions haven't affected supply, the FDA said.

Reblozyl, a key drug in Bristol Myers Squibb's Celgene merger, has won a key FDA nod to treat patients with myelodysplastic syndromes.

Wealthy individuals typically don't set out to waste billions of dollars, but amid the COVID-19 pandemic, that’s exactly what Bill Gates plans to do.